Parental preferences for rotavirus vaccination in young children: A discrete choice experiment

Veldwijk, Jorien; Lambooij, Mattijs; Bruijning-Verhagen, Patricia; Smit, Henriëtte A.; Wit, G. Ardine de

doi:10.1016/j.vaccine.2014.09.004

Cited by 46 publications

(69 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our study also found that price was an important attribute driving preferences which is in line with previous research [9, 11, 31, 50, 51]. Recommended but non-publicly funded vaccines were more likely to be refused by parents due to the price [50].…”

Section: Discussionsupporting

confidence: 91%

“…Previous research only assessed impact of the frequency of severe reactions [9, 30, 33, 34]. Our study compared preferences between two common occurrences of side effects: rare but serious versus common but mild.…”

Section: Discussionmentioning

confidence: 99%

“…A rapid systematic review was performed by searching titles and abstracts in the PubMed database for DCE studies investigating vaccines preferences. Experts were asked to review the list of attributes derived from the literature review, and the following were identified as appropriate to include in our DCE: disease target [26–29], location of vaccination [9, 13, 30, 31], potential for side effects [8–10, 13, 30–35], vaccine delivery mechanism [10] and price [9, 10, 13, 30, 31, 35, 36]. Since herd protection is an important factor affecting acceptance of vaccines and outcomes of cost-effectiveness evaluations [37], “target for protection” was also added to the attribute list based on the expert opinion.…”

Section: Methodsmentioning

confidence: 99%

“…Where price is included as an additional attribute, the DCE approach may also be used to estimate individuals’ willingness to pay (WTP) for healthcare interventions [16]. Immunisation acceptance by adolescents may be influenced by a number of factors including severity of illness, side effects, out-of-pocket costs, healthcare facilities where vaccines are administered, mode of administration, vaccine effectiveness and duration of immunity [9, 12]. Adolescents may choose to trade off the potential health benefits against perceived drawbacks of immunisation in the decision making dynamic.…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Adolescent values for immunisation programs in Australia: A discrete choice experiment

et al. 2017

View full text Add to dashboard Cite

ObjectivesThe importance of adolescent engagement in health decisions and public health programs such as immunisation is becoming increasingly recognised. Understanding adolescent preferences and further identifying barriers and facilitators for immunisation acceptance is critical to the success of adolescent immunisation programs. This study applied a discrete choice experiment (DCE) to assess vaccination preferences in adolescents.MethodsThis study was conducted as a cross-sectional, national online survey in Australian adolescents. The DCE survey evaluated adolescent vaccination preferences. Six attributes were assessed including disease severity, target for protection, price, location of vaccination provision, potential side effects and vaccine delivery method. A mixed logit model was used to analyse DCE data.ResultsThis survey was conducted between December 2014 and January 2015. Of 800 adolescents aged 15 to 19 years, stronger preferences were observed overall for: vaccination in the case of a life threatening illness (p<0.001), lower price vaccinations (p<0.001), mild but common side effects (p = 0.004), delivery via a skin patch (p<0.001) and being administered by a family practitioner (p<0.001). Participants suggested that they and their families would be willing to pay AU$394.28 (95%CI: AU$348.40 to AU$446.92) more for a vaccine targeting a life threatening illness than a mild-moderate illness, AU$37.94 (95%CI: AU$19.22 to AU$57.39) more for being vaccinated at a family practitioner clinic than a council immunisation clinic, AU$23.01 (95%CI: AU$7.12 to AU$39.24) more for common but mild and resolving side effects compared to rare but serious side effects, and AU$51.80 (95%CI: AU$30.42 to AU$73.70) more for delivery via a skin patch than injection.ConclusionsConsideration of adolescent preferences may result in improved acceptance of, engagement in and uptake of immunisation programs targeted for this age group.

show abstract

Section: Discussionsupporting

confidence: 91%

Section: Discussionmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Adolescent values for immunisation programs in Australia: A discrete choice experiment

et al. 2017

View full text Add to dashboard Cite

show abstract

“…[34] The panel recommended the referendum format used here for its realism, and lack of incentive to misreport. Stated-preference methods have been applied to the context of vaccination [13, 22–25], and there is some evidence of substantial concordance with actual behavior. [51]…”

Section: Discussionmentioning

confidence: 99%

National Survey Indicates that Individual Vaccination Decisions Respond Positively to Community Vaccination Rates

2016

View full text Add to dashboard Cite

Some models of vaccination behavior imply that an individual’s willingness to vaccinate could be negatively correlated with the vaccination rate in her community. The rationale is that a higher community vaccination rate reduces the risk of contracting the vaccine-preventable disease and thus reduces the individual’s incentive to vaccinate. At the same time, as for many health-related behaviors, individuals may want to conform to the vaccination behavior of peers, counteracting a reduced incentive to vaccinate due to herd immunity. Currently there is limited empirical evidence on how individual vaccination decisions respond to the vaccination decisions of peers. In the fall of 2014, we used a rapid survey technology to ask a large sample of U.S. adults about their willingness to use a vaccine for Ebola. Respondents expressed a greater inclination to use the vaccine in a hypothetical scenario with a high community vaccination rate. In particular, an increase in the community vaccination rate from 10% to 90% had the same impact on reported utilization as a nearly 50% reduction in out-of-pocket cost. These findings are consistent with a tendency to conform with vaccination among peers, and suggest that policies promoting vaccination could be more effective than has been recognized.

show abstract

Factors Associated With US Adults’ Likelihood of Accepting COVID-19 Vaccination

et al. 2020

View full text Add to dashboard Cite

IMPORTANCE The development of a coronavirus disease 2019 (COVID-19) vaccine has progressed at unprecedented speed. Widespread public uptake of the vaccine is crucial to stem the pandemic. OBJECTIVE To examine the factors associated with survey participants' self-reported likelihood of selecting and receiving a hypothetical COVID-19 vaccine. DESIGN, SETTING, AND PARTICIPANTS A survey study of a nonprobability convenience sample of 2000 recruited participants including a choice-based conjoint analysis was conducted to estimate respondents' probability of choosing a vaccine and willingness to receive vaccination. Participants were asked to evaluate their willingness to receive each hypothetical vaccine individually. The survey presented respondents with 5 choice tasks. In each, participants evaluated 2 hypothetical COVID-19 vaccines and were asked whether they would choose vaccine A, vaccine B, or neither vaccine. Vaccine attributes included efficacy, protection duration, major adverse effects, minor adverse effects, US Food and Drug Administration (FDA) approval process, national origin of vaccine, and endorsement. Levels of each attribute for each vaccine were randomly assigned, and attribute order was randomized across participants. Survey data were collected on July 9, 2020. MAIN OUTCOMES AND MEASURES Average marginal component effect sizes and marginal means were calculated to estimate the relationship between each vaccine attribute level and the probability of the respondent choosing a vaccine and self-reported willingness to receive vaccination. RESULTS A total of 1971 US adults responded to the survey (median age, 43 [interquartile range, 30-58] years); 999 (51%) were women, 1432 (73%) White, 277 (14%) were Black, and 190 (10%) were Latinx. An increase in efficacy from 50% to 70% was associated with a higher probability of choosing a vaccine (coefficient, 0.07; 95% CI, 0.06-0.09), and an increase from 50% to 90% was associated with a higher probability of choosing a vaccine (coefficient, 0.16; 95% CI, 0.15-0.18).

show abstract

Parental preferences for rotavirus vaccination in young children: A discrete choice experiment

Cited by 46 publications

References 33 publications

Adolescent values for immunisation programs in Australia: A discrete choice experiment

Adolescent values for immunisation programs in Australia: A discrete choice experiment

National Survey Indicates that Individual Vaccination Decisions Respond Positively to Community Vaccination Rates

Factors Associated With US Adults’ Likelihood of Accepting COVID-19 Vaccination

Contact Info

Product

Resources

About